Healthcare is changing.
As chronic diseases place growing pressure on patients, healthcare systems, and society, new approaches are needed to improve how we predict, prevent, and personalize care.
Better healthcare starts with better disease understanding.
A new conversation begins June 17 🎙️
Rowan Gardner (@rowanbio.bsky.social) will present new DecodeME analysis at #IIMEC18:
'Expanding Mechanistic Insights in ME - Analysis of DecodeME population and what’s next'
New insights into ME/CFS and long COVID biology, patient stratification, and future research directions.
#MECFS #LongCOVID
Our new paper out today in Nature Comms, led by the amazing @profmarkfaghy.bsky.social
Current status and future perspectives on the mechanistic And pathophysiological understanding of Long Covid
www.nature.com/articles/s43...
PrecisionLife & Ovation are bringing precision medicine to GLP-1s - with new genetic markers predicting response and tests launching in 2026.
This creates a significant opportunity to improve outcomes for patients, payors, providers, and pharma.
Learn more here: precisionlife.com/news-and-eve...
Presenting new research at #EEC2026
Our talk on genomic signatures of female #infertility in #endometriosis & related conditions was selected for the best abstracts session.
24 Apr | 11:30
Krystyna Taylor presenting
There's still time to sign up for our second workshop for our PRIME research project!
📅 When? Friday 24 April, 2-5pm GMT
📍 Online
🔗 Register to attend: us02web.zoom.us/webinar/regi...
👉 Read the full programme: www.actionforme.org.uk/prime-worksh...
what might these findings mean?
precisionlife.com/glp1
What might these findings mean?
precisionlife.com/glp1
Very excited to see how fast these insighgts emerge with top quality data from @precisionlife.bsky.social partner Ovation.
precisionlife.com/news-and-eve...
#genomics #PMWC #precisionmedicine 🧬🖥️
Faghy et al., review the current literature on Long COVID pathophysiology, linking immune dysregulation, viral persistence, and vascular injury to enduring symptoms. They highlight evidence to guide f...
PrecisionLife and Ovation are developing a test to predict GLP-1 drug response, enabling precision prescribing and sustainable access to these therapies.
precisionlife.com
PrecisionLife and Ovation are developing a test to predict GLP-1 drug response, enabling precision prescribing and sustainable access to these therapies.
Fantastic @daphnezohar.bsky.social men and women advocating for and celebrating women. Greatly needed in an era of anti - woke/DEI/Science. Leaders that bring common values and vision and to achieving the goal of finding news cures. Wear pink one day, pack a pink perspective every day.
